论文部分内容阅读
科技部重点攻关项目和“十五”攻关项目及北京中医药大学“211”工程项目——“抗栓素的产业化开发与研究”表明:抗栓素具有良好防治血栓性疾病的作用。 据介绍,抗栓素前体来源于中药的单体化合物。该类中药在我国资源分布较广,而且个别种属中的抗栓素前体含量可高达12%。经过一定的结构修饰,衍生出的新化合
The key projects of the Ministry of Science and Technology and the “Tenth Five-Year Plan” project and the “211” Project of Beijing University of Traditional Chinese Medicine - “Development and Research of Industrialization of Antithrombotic Drugs” show that antithrombotic drugs have a good effect in preventing and treating thrombotic diseases. According to reports, anti-peptanoid precursors derived from traditional Chinese medicine monomer compounds. This type of Chinese medicine is widely distributed in our country, and the content of anti-anthropoietin precursor in individual species can be as high as 12%. After a certain structural modification, new chemical compounds are derived.